SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Health is trending as investors react to a significant acquisition that expands its late-stage liver disease pipeline, sparking community debate over the company's long-term debt management and the stalled monetization of its Bausch + Lomb asset. While the stock has seen renewed volume and volatility, traders remain divided on whether this move signals a sustainable turnaround or just another cycle of institutional manipulation and stagnant performance.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors weigh significant short interest against ongoing share repurchases and strategic growth initiatives, including international expansion and partnerships within the autonomous vehicle sector. The community remains divided, with some highlighting the stock's potential for a short squeeze and long-term value, while others express frustration over stagnant price action and competitive pressures in the rideshare market.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc is experiencing significant volatility and a sharp selloff despite delivering a strong quarterly earnings beat, as investors grow increasingly concerned over the durability of the platform's user growth and its dependency on Google search referrals. The community is actively debating the stock's long-term potential, with some bulls viewing the dip as a prime buying opportunity based on strong revenue fundamentals, while bears and skeptics highlight ongoing issues with platform moderation and potential headwinds from AI-driven search.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen Inc. is seeing intense investor focus as community members debate its competitive positioning against Inovio following recent volatility, while many look toward upcoming quarterly financial results for signs of sustained revenue growth. Discussion is heavily centered on the company's commercial rollout, potential institutional accumulation, and the market's reaction to potential competitive threats in the rare disease space.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors react to the launch of their second-generation driverless trucks, sparking discussions around the company's path to commercial scalability and the strengthening of their logistics ecosystem. While technical analysts monitor breakout levels and volume, community members are actively debating the company's long-term potential versus concerns over cash burn and short interest.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF is experiencing a period of intense volatility as investors weigh the implications of aggressive institutional rotation into small-cap biotech names against broader macroeconomic uncertainty. The community is actively debating the strength of this sector-wide move, with bulls betting on sustained price appreciation driven by institutional inflows and upcoming clinical catalysts, while bears remain wary of valuation overextensions and potential cyclical risks.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ remains a focal point for income-focused investors who are actively monitoring the ETF's dividend distributions and price volatility. Community sentiment centers on the fund's utility as a core income engine, with many users employing dollar-cost averaging strategies to accumulate shares, despite ongoing debates regarding its comparative total returns against other Nasdaq-focused income ETFs.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed momentum driven by speculative retail interest and whale activity, with the community actively debating whether this movement represents a sustainable breakout or another temporary pump. Traders are closely monitoring burn rates and liquidity levels while speculating on the potential for a larger meme coin rally.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending following reports of advanced acquisition talks for Delivery Hero, a move intended to significantly scale its global food delivery and commerce footprint. The community remains divided, with bullish investors highlighting the strategic expansion of the platform's 'super app' ecosystem, while skeptics express concern over the potential costs and integration challenges associated with such a large-scale deal.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors closely monitor a potential anchor tenant announcement that could serve as a major catalyst for the stock's valuation. While community sentiment is split between bullish long-term expectations for its massive energy project and skepticism over cash burn and leadership changes, active discussion is dominated by the strategic positioning ahead of upcoming performance incentive deadlines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LEGN Stock Plunges 15% After Sudden CEO Exit — But Analyst Reiterates Optimism In Company’s Under-Development Lymphoma Asset 

Equity

Legend said on Monday that Ying Huang stepped down as chief executive officer and board member effective July 24. 


Sellas CEO Angelos Stergiou Says ‘100% Certain’ AI Can Be Used To Beat Cancer 

public companies

During an interview on Fox & Friends on Friday, Stergiou said AI will play a major role in helping cure cancer by enabling more precise treatments.

OTLK Stock Generates Buzz Ahead Of FDA Decision On Wet AMD Therapy – Retail Says Favorable Verdict Could Cause A ‘Big Boom’

After two rejections, retail investors are hopeful the FDA will approve Outlook Therapeutics’ Lytenava for the treatment of wet AMD.


VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

Wall Street sees bigger upside in VKTX, with Koyfin’s average target implying 120% upside versus 99% for BCRX.

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

Multiple analysts reiterated optimism on CMPS stock after the company announced 26-week data from its second late-stage trial of COMP360 in treatment-resistant depression.


AGIO Stock Hits Over 7-Month Highs – FDA Catalyst, ‘Seasonally Strong’ Q2 Earnings Estimate Drive Optimism

Agios said the U.S. Food and Drug Administration granted Priority Review to its supplemental new drug application for Mitapivat in sickle cell disease.

ABVX Stock Clocks Best Day In 11 Months On Analyst Upgrades After Fresh Data Eases Drug Safety Concerns 

Wedbush, BTIG and Jefferies weighed in on ABVX on Tuesday after the company unveiled updated safety and efficacy data from an obefazimod study. 


ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data

Abivax said the findings strengthen the overall case for obefazimod and reinforce its favorable benefit-risk profile.


Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know

Larimar submitted the module of a rolling biologics license application to the U.S. Food and Drug Administration for the accelerated approval of nomlabofusp for Friedreich’s ataxia.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

iShares Trust - iShares Biotechnology ETF

Neutral Sentiment

< 1 yr

1 - 3 yrs

3 - 10 yrs

10+ yrs

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

What is your typical investment horizon? 
 
*Sponsored by Calamos and S&P Global

Feed

News

Sentiment

Fundamentals

Info

IBBiShares Biotechnology ETF

Fundamentals

Connect Stocktwits to ChatGPT

Latest IBB News